Prof. Dr. rer. nat. Dr. habil. med. Stefan Lyer

Educational activity

• Lecturer: FelasaB course at the Franz Penzoldt Center
• Lecturer: Lecture "Metallic Nanoparticles in Medicine" at the Faculty of Science of FAU, organized by Prof. Kryschi
• Lecturer: Seminar series "Preparation for scientific work for physicians in the 2nd semester", at the medical faculty of FAU Erlangen/Nuremberg, organized by Prof. Schiebel
• Lecturer: Lecture "Biomedical Applications in Nanomedicine and Nanotoxicology" at the Faculty of Natural Sciences of FAU/Nuremberg
• Supervision of seminar, bachelor and master theses of the Natural Science and Technical Faculty of the FAU Erlangen/Nuremberg.
• Supervision of PhD projects from the Medical and Technical Faculty of the FAU Erlangen/Nuremberg

Scientific activity
General: Development and in vitro/in vivo application of superparamagnetic iron oxide nanoparticles (SPIONs) for medical applications in imaging, oncology, atherosclerosis and infectious diseases

Projects:

• Magnetic drug targeting in oncology.
• Magnetic Drug Targeting in Arteriosclerosis
• Integration of robotics into treatment procedures for magnetic drug targeting in the treatment of tumors and arteriosclerosis
• Development of flow phantoms for the study of physical parameters in Magnetic Drug Targeting in preparation for the use of self-learning algorithms.
• Alignment of simulations and experiments/flow tests for Magnetic Drug Targeting.
• Combination of magnetic drug targeting and magnetic hyperthermia (DFG proposal submitted).
• Magnetic resonance imaging in the field of oncology and arteriosclerosis
• Imaging of liver tumors in MRI (funded by: Manfred Roth Foundation)
• Ultrasound imaging of nanoparticles (DFG funding)
• Comparison of imaging properties/biocompatibility of different commercial nanoparticles and SEON nanoparticles (funded by: Else Kröner-Freseniusstiftung)
• Generation of cell lines in the field of ENT oncology
• Sepsis diagnostics - and treatment (funded by: Dr. Robert-Pfleger Stiftung)
• Method transfer for the approval of nanoparticles
• In vitro diagnostics of diseases, e.g. SarsCov2 antibody status

Deputy Head of SEON
Head of Oncology and Imaging Unit
Safety Officer
S1 Project Manager
Biological Safety Officer - Radiation Clinic

Memberships:

Societas Physico-Medica Erlangensis
University Association Erlangen-Nuremberg e.V.
Ferrofluid Association Germany e.V.
German Platform NanoBiomedicine

2005 - Poster Award of the Falk Foundation at the International Meeting "Inflammatory Diseases of Barrier Organs", Kiel